Page last updated: 2024-09-02

cotinine-n-oxide and Diabetes Mellitus, Type 2

cotinine-n-oxide has been researched along with Diabetes Mellitus, Type 2 in 1 studies

*Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
El-Din Selim, MM; Graaff, R; Lutgers, HL; Mook-Kanamori, DO; Mook-Kanamori, MJ; Slagter, SN; Suhre, K; van der Klauw, MM; van Vliet-Ostaptchouk, JV; van Waateringe, RP; Wolffenbuttel, BHR1

Other Studies

1 other study(ies) available for cotinine-n-oxide and Diabetes Mellitus, Type 2

ArticleYear
The association between various smoking behaviors, cotinine biomarkers and skin autofluorescence, a marker for advanced glycation end product accumulation.
    PloS one, 2017, Volume: 12, Issue:6

    Topics: Adult; Aged; Biomarkers; Cohort Studies; Cotinine; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Glycation End Products, Advanced; Humans; Male; Middle Aged; Saliva; Skin; Smoking; Smoking Cessation; Spectrometry, Fluorescence; Time Factors; Tobacco Smoke Pollution

2017